Study on the correlation between carotid artery intraplaque neovascularization and serum inflammation markers

Study on the correlation between carotid artery intraplaque neovascularization and serum inflammation markers in patients with non-acute ischemic stroke

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100052836

Enrollment

Unknown

Registered

2021-11-06

Start date

2021-12-01

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral vascular disease

Interventions

IPN (Intraplaque neovascularization) group A:No

IPN group B:No

Eligibility

Sex/Gender

All

Age

45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 45 to 80 years, with carotid artery plaques in non-acute ischemic stroke; 2. Carotid plaque thickness more than 2 mm by identified by carotid Duplex ultrasound examination.

Exclusion criteria

Exclusion criteria: 1. There are contraindications of receiving ultrasound contrast agent intravenous administration, such as acute heart failure, unstable angina, acute endocarditis, known right-to-left shunt of heart, allergies to ultrasound contrast agent; 2. Patients with acute infection, liver and kidney insanity, combined tumors, acute myocardial infarction, connective tissue disease; 3. Contrast-enhanced ultrasound image acquisition cannot assess intraplaque neovascularization.

Design outcomes

Primary

Measure	Time frame
Degree of carotid artery intraplaque neovascularization;Serum inflammatory factors;	—

Countries

China

Contacts

Public ContactShi Zhu

Dongguan People's Hospital

sound_shi@126.com+86 769 2267 9351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026